Sinaptica Therapeutics
Does Sinaptica Therapeutics sponsor H-1B visas?
Yes. Sinaptica Therapeutics filed 2 H-1B applications in fiscal year 2026. USCIS approved 100% of its petitions.
- No green card filingsNone in FY2026
- E-Verify not confirmedAsk before relying on STEM OPT
- Cap-exempt not confirmedCommon for this kind of employer. Ask before relying on it
Checked against Department of Labor and USCIS records on Nov 20, 2026.
H-1B filings in FY2026
2
Petitions approved
100%
Median H-1B pay
No data
H-1B filings per year
U.S. fiscal years run October to September.
Show as a table
| Fiscal year | H-1B filings |
|---|---|
| FY2026 | 2 |
Where they sponsor
Work location on FY2026 filings.
Remote roles are filed under the employee's home address.
Open jobs at Sinaptica Therapeutics
Questions about Sinaptica Therapeutics and visas
Does Sinaptica Therapeutics sponsor green cards?
Sinaptica Therapeutics filed no PERM applications, the first step of an employment-based green card, in fiscal year 2026.
Does Sinaptica Therapeutics hire international students on OPT?
We couldn't confirm whether Sinaptica Therapeutics uses E-Verify, which STEM OPT requires. Ask the recruiter.
Is Sinaptica Therapeutics cap-exempt?
We haven't confirmed it. Universities, their affiliated nonprofits, nonprofit research groups and government research groups are cap-exempt, so they can file new H-1B petitions all year without the lottery. Ask Sinaptica Therapeutics whether it files as cap-exempt.
Similar sponsors
-
AbelZeta
Research and development, Rockville. 2 filings in FY2026.
-
Abinitia Labs
Research and development, San Francisco. 2 filings in FY2026.
-
Abio Technologies
Research and development, Redwood City. 2 filings in FY2026.
-
Absci
Research and development, Vancouver. 2 filings in FY2026.
Where these numbers come from
- H-1B filings and pay: U.S. Department of Labor, LCA disclosure data, FY2020 to FY2026.
- Filed as: Sinaptica Therapeutics, Inc. (2 in FY2026).
- Approvals: USCIS H-1B Employer Data Hub, FY2020 to FY2026.
- Green card filings: U.S. Department of Labor, PERM disclosure data, FY2020 to FY2026.
These are public records of what Sinaptica Therapeutics has done, not a promise to sponsor you. How we read the data.